Lucid Diagnostics Inc. (LUCD) Shareholders’ equity 2021–2025
Lucid Diagnostics Inc. (LUCD) shareholders’ equity at each fiscal year-end, per SEC filings.
$10.9MFY2025 · since FY2021: $54.7M → $10.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.9M | +102.9% |
| FY2024 | $5.4M | +333.3% |
| FY2023 | -$2.3M | -110.0% |
| FY2022 | $23.0M | -57.9% |
| FY2021 | $54.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice